Vitro Diagnostics Inc. (fka VODG)

[Potse]

aboveandbeyond...next few months/quarters......

I did ask Jim's permission to share the following information about the filings. Given the importance of the medical work it was simply not possible to file Q2 on time. Q2 and Q3 should be filed together when the Q3 filing is due in mid-September.

Musick will also need to get the company's Nevada filings updated (business license renewal, annual list, late fees, etc).....

http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=50v5fEl3MAi%252fzzAE3s9XnQ%253d%253d&nt7=0

VODG's press releases this year and the information contained in the redesign/update of the company's website in May/June, appears to have set the stage for what could be quite an interesting time in the company's history. Assuming the company gets its filing obligations back in compliance and on schedule, we should be getting 3 periodic reports (two quarterly reports and a detailed 10-K) within the next 5 months.

It should be very interesting to see if there is a significant increase in revenue in Q2/Q3 as a result of the MSC-Gro order(s) from the foreign customer. The timing/content of the positive forward guidance statement (August 2014) and the announcement of the MSC-Gro business agreement (April 2015) suggests a probable strong connection between the two things. My guess/hunch is that Musick/Shuster were expecting this particular supply agreement to begin sometime in Q1, but the deal got pushed back into Q2/Q3.